- Messages
- 17,355
- Reaction score
- 756
- Points
- 263
Given that Stephen Johnsons can eventually end in death, I would say someone else's lack of side effects doesn't really come into the equation.
Stevens Johnson Syndrome is obviously extremely serious -- that's why Lamictal is titrated up so slowly, and patients are instructed to watch out for any hypersensitivity reactions during the process. Many folks who present with SJS also have serious allergic reactions to other medications, perhaps as a result of an underlying immune issue. Overall, Stevens-Johnson Syndrome occurs in approx. 6.1 cases per million annually. It's a very serious side effect with a low rate of occurrence.
It's also possible to respond with an allergic reaction to the med without it being SJS. In these cases, studies have shown that it's still possible to reintroduce Lamictal, but with a much slower ramp-up.
I agree that being alert to these potential reactions is crucial when starting Lamictal, particularly if there's a prior history of medication sensitivity. This doesn't mean that people with epilepsy should avoid it altogether, nor does it mean that folks who have positive experiences with Lamictal shouldn't offer up their perspectives as well.